CHMP6 Antikörper (AA 2-201)

Produktnummer ABIN7147533

Produktdetails anti-CHMP6 Antikörper

Target: CHMP6 (Charged Multivesicular Body Protein 6 (CHMP6))

Bindungsspezifität: AA 2-201

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser CHMP6 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Kreuzreaktivität: Human, Ratte

Aufreinigung: >95%, Protein G purified

Immunogen: Recombinant Human Charged multivesicular body protein 6 protein (2-201AA)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200,

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu CHMP6

Target: CHMP6 (Charged Multivesicular Body Protein 6 (CHMP6))

Andere Bezeichnung: CHMP6 (CHMP6 Produkte)

Synonyme: chmp6 antikoerper, vps20 antikoerper, 2400004G01Rik antikoerper, VPS20 antikoerper, RGD1565325 antikoerper, chmp6l antikoerper, flj11749l antikoerper, wu:fb79d02 antikoerper, zgc:110067 antikoerper, charged multivesicular body protein 6 antikoerper, charged multivesicular body protein 6 L homeolog antikoerper, charged multivesicular body protein 6 S homeolog antikoerper, charged multivesicular body protein 6b antikoerper, LOC100280982 antikoerper, chmp6.L antikoerper, chmp6.S antikoerper, CHMP6 antikoerper, chmp6 antikoerper, Tsp_08316 antikoerper, Chmp6 antikoerper, chmp6b antikoerper

Hintergrund:

Background: Probable core component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The MVB pathway appears to require the sequential function of ESCRT-O, -I,-II and -III complexes. ESCRT-III proteins mostly dissociate from the invaginating membrane before the ILV is released. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis and the budding of enveloped viruses (HIV-1 and other lentiviruses). ESCRT-III proteins are believed to mediate the necessary vesicle extrusion and/or membrane fission activities, possibly in conjunction with the AAA ATPase VPS4. In the ESCRT-III complex, it probably serves as an acceptor for the ESCRT-II complex on endosomal membranes.

Aliases: Charged multivesicular body protein 6 antibody, chmp6 antibody, CHMP6_HUMAN antibody, Chromatin modifying protein 6 antibody, Chromatin-modifying protein 6 antibody, FLJ11749 antibody, hVps 20 antibody, hVps20 antibody, novel SNF7 protein antibody, OTTMUSP00000004363 antibody, RGD1565325 antibody, RP24 225K18.4 antibody, Vacuolar protein sorting associated protein 20 antibody, Vacuolar protein sorting-associated protein 20 antibody, Vps 20 antibody, Vps20 antibody

UniProt: Q96FZ7